<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03862599</url>
  </required_header>
  <id_info>
    <org_study_id>250004</org_study_id>
    <nct_id>NCT03862599</nct_id>
  </id_info>
  <brief_title>Low Intensity Shock-wave Therapy (Li-ESWT) in Penile Rehabilitation After Radical Prostatectomy</brief_title>
  <acronym>LiST-PRP</acronym>
  <official_title>Low Intensity Extracorporeal Shock-wave Therapy (Li-ESWT) in Penile Rehabilitation After Radical Prostatectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guy's and St Thomas' NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guy's and St Thomas' NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Erectile dysfunction (ED) is reported in up to 85% of men who have undergone a radical
      prostatectomy for prostate cancer. A few small studies have recently shown that low-intensity
      shockwave therapy may improve sexual performance in men with ED. However, the optimal dosage
      and length of treatment is yet to be determined. The investigators propose a randomised trial
      evaluating the efficacy and safety of low-intensity shockwave therapy in men with ED
      following prostatectomy surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Erectile dysfunction (ED) is reported in up to 85% of men who have undergone a radical
      prostatectomy for prostate cancer. At present, this debilitating consequence of surgery is
      managed in a step-wise approach including oral medication, injections and in severe cases,
      insertion of a penile prosthesis. A few small studies have shown that low-intensity shockwave
      therapy may improve sexual performance in men with ED. However, the optimal dosage and length
      of treatment is yet to be determined. The investigators propose a randomised trial evaluating
      the efficacy and safety of low-intensity shockwave therapy in men with ED following
      prostatectomy surgery. Low-intensity shockwave therapy would be a non-invasive treatment to
      preserve and improve patient's sexual function.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2020</start_date>
  <completion_date type="Anticipated">January 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomised controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Masking of probe applicator at device manufacturer before ESWT use</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Sexual Function</measure>
    <time_frame>6 months</time_frame>
    <description>Measurement of average change in IIEF-ED from baseline (pre-RP) to 24 week-FU 22-25: No erectile dysfunction 17-21: Mild erectile dysfunction 12-16: Mild to moderate erectile dysfunction 8-11: Moderate erectile dysfunction 5-7: Severe erectile dysfunction 5 being the worst outcome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Penile length</measure>
    <time_frame>12 months</time_frame>
    <description>Clinical measurement of change in stretched flaccid penile length from baseline and time points to 12 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary Incontinence</measure>
    <time_frame>12 months</time_frame>
    <description>Measurement of average change in EPIC questionnaire from baseline (pre-RP) to 24 week-FU and time points to 12 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>12 months</time_frame>
    <description>Number of Participants With Treatment-Related Adverse Events as Assessed by CTCAE v4.0</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Erectile Dysfunction Following Radical Prostatectomy</condition>
  <arm_group>
    <arm_group_label>Standard care + sham ESWT</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Cialis and Vacuum pump + sham Extra-corporeal shockwave therapy (ESWT)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard care + active ESWT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cialis and Vacuum pump + active Extra-corporeal shockwave therapy (ESWT)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Extra-corporeal shockwave therapy (ESWT)</intervention_name>
    <description>low-intensity extra-corporeal shockwave therapy</description>
    <arm_group_label>Standard care + active ESWT</arm_group_label>
    <arm_group_label>Standard care + sham ESWT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard care</intervention_name>
    <description>Cialis and vacuum pump</description>
    <arm_group_label>Standard care + active ESWT</arm_group_label>
    <arm_group_label>Standard care + sham ESWT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 40 - 65

          -  Diagnosed with low/intermediate-risk prostate cancer:

          -  PSA &lt; 20 ng/ml

          -  Gleason score &lt; 8

          -  PCa stage =&lt; T2b

          -  Baseline IIEF-ED 17-30 without erectogenic aids

          -  No urinary incontinence (no usage of urinary pads)

          -  Sexually active

          -  Able to understand and complete patient questionnaires

          -  Consent to participate

        Exclusion Criteria:

          -  Anatomical abnormalities in the genitalia or pelvic region

          -  Post-RP complications that could impact safety or effectiveness of ESWT (eg. hematoma,
             fistula, unresolved anastomotic leak)

          -  Incomplete tumor removal (positive surgical margin)

          -  Tumor upstaging beyond T2b

          -  Nerve sparing score &gt; 5

          -  Previous or scheduled treatment with pelvic radiotherapy and/or androgen deprivation
             therapy

          -  Untreated hypogonadism (serum total testosterone &lt; 300 mg/dL)

          -  Anti-coagulant medication, except acetylsalicyclic acid up to 100mg daily

          -  Any other condition that would prevent the patient from completing the study, as
             judged by the principle investigator
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tet Yap, FRCS (Urol)</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guy's and St Thomas' NHS Foundation Trust</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tet Yap, FRCS (Urol)</last_name>
    <phone>07780611631</phone>
    <email>tet-yap@gstt.nhs.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Arunan Sujenthiran, MRCS</last_name>
    <phone>07834830425</phone>
    <email>asujenthiran@doctors.org.uk</email>
  </overall_contact_backup>
  <reference>
    <citation>Kalyvianakis D, Memmos E, Mykoniatis I, Kapoteli P, Memmos D, Hatzichristou D. Low-Intensity Shockwave Therapy for Erectile Dysfunction: A Randomized Clinical Trial Comparing 2 Treatment Protocols and the Impact of Repeating Treatment. J Sex Med. 2018 Mar;15(3):334-345. doi: 10.1016/j.jsxm.2018.01.003. Epub 2018 Feb 1.</citation>
    <PMID>29396020</PMID>
  </reference>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 10, 2018</study_first_submitted>
  <study_first_submitted_qc>March 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2019</study_first_posted>
  <last_update_submitted>October 22, 2019</last_update_submitted>
  <last_update_submitted_qc>October 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guy's and St Thomas' NHS Foundation Trust</investigator_affiliation>
    <investigator_full_name>Tet Yap</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>erectile dysfunction</keyword>
  <keyword>shockwave</keyword>
  <keyword>treatment</keyword>
  <keyword>prostatectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

